Argent Advisors, Inc. Merck & Co., Inc. Transaction History

Argent Advisors, Inc.

$285 Million
Q1 2025

A detailed history of Argent Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Argent Advisors, Inc. holds 20,603 shares of MRK stock, worth $1.76 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

20,603

Previous 16,574 24.31%

Holding current value

$1.76 Million

Previous $1.65 Million 12.2%

% of portfolio

0.65%

Previous 0.63%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$83.01 - $101.02 $334,447 - $407,009	4,029 Added 24.31%	20,603 $1.85 Million
Q4 2024 Feb 10, 2025	BUY	$96.31 - $114.76 $34,767 - $41,428	361 Added 2.23%	16,574 $1.65 Million
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $44,460 - $51,588	-400 Reduced 2.41%	16,213 $1.84 Million
Q2 2024 Jul 29, 2024	BUY	$123.8 - $132.96 $3,095 - $3,324	25 Added 0.15%	16,613 $2.06 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $11,324 - $13,194	-100 Reduced 0.6%	16,588 $2.19 Million
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $16,930 - $18,424	-169 Reduced 1.0%	16,688 $1.82 Million
Q3 2023 Nov 08, 2023	SELL	$102.95 - $114.33 $6,588 - $7,317	-64 Reduced 0.38%	16,857 $1.74 Million
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $25,088 - $27,345	-231 Reduced 1.35%	16,921 $1.95 Million
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $104,895 - $117,042	-1,019 Reduced 5.61%	17,152 $1.82 Million
Q4 2022 Feb 01, 2023	SELL	$87.44 - $112.11 $35,500 - $45,516	-406 Reduced 2.19%	18,171 $2.02 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $18,765 - $21,081	-222 Reduced 1.18%	18,577 $1.6 Million
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $3,590 - $4,069	-43 Reduced 0.23%	18,799 $1.71 Million
Q1 2022 Apr 26, 2022	BUY	$73.51 - $82.4 $97,327 - $109,097	1,324 Added 7.56%	18,842 $1.55 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $11,275 - $14,124	156 Added 0.9%	17,518 $1.34 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $148,592 - $163,414	2,073 Added 13.56%	17,362 $1.3 Million
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $73,122 - $80,880	1,040 Added 7.3%	15,289 $1.19 Million
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $51,920 - $61,156	754 Added 5.59%	14,249 $1.1 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $102,200 - $113,421	1,424 Added 11.8%	13,495 $1.1 Million
Q3 2020 Oct 29, 2020	BUY	$73.18 - $82.95 $26,344 - $29,862	360 Added 3.07%	12,071 $1 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $69,434 - $79,008	986 Added 9.19%	11,711 $905,000
Q1 2020 Apr 23, 2020	BUY	$63.36 - $87.82 $3,421 - $4,742	54 Added 0.51%	10,725 $825,000
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $827,856 - $934,139	10,671 New	10,671 $975,000

Others Institutions Holding MRK

# of Institutions

3,905

Shares Held

1.85B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $216B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Merck & Co., Inc. Transaction History